ArticleJournal for immunotherapy of cancer2026
Telmisartan increases olaparib efficacy in homologous recombination proficient tumors by augmenting type I interferon production.
Clare E Murray et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.